Greetings:
In this week's Eblast we offer the following new postings:
Hepatitis C:
-
Victrelis Warning: Merck has issued a ‘Dear Health Care Professional” letter to alert medical providers that a recently released study of drug-drug interactions between Victrelis (boceprevir) and certain HIV medications were found to lower the blood concentrations of HIV and/or HCV medications. Click here
-
HIV/HCV Coinfection Guide: This new guide provides basic information about having HIV and hepatitis C coinfection. Click here
-
Stigma Slideshow from our friends at the Haymarket Center in Chicago who do really good work with underserved populations. Click here
Hepatitis and Tattoos:
-
Be sure to check out our Hepatitistattoos.org Website blog to read about the new story on the risk of hepatitis C transmission and tattoos. Click here
HBV and HCV Blog:
Read about the latest and greatest in the news
Respectfully,
Alan
Alan Franciscus
Executive Director, Hepatitis C Support Project
Editor-in-Chief, HCV Advocate www.hcvadvocate.org
Editor-in-Chief, HBV Advocate www.hbvadvocate.org
**Questions and Comments: Questions and/or comments can be directed to alanfranciscus@hcvadvocate.org
**To receive the eblast in your email inbox simply send an e-mail to: listserv@list.hcvadvocate.org with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.
|
|
 |
 |
|
